EMAIL THIS PAGE TO A FRIEND

Bioconjugate chemistry

Synthesis of oxytocin HYNIC derivatives as potential diagnostic agents for breast cancer.


PMID 17665873

Abstract

Two synthetic procedures for HYNIC oxytocin labeling were developed: one based on an orthogonal protection approach and the other with prelabeled (Boc)HYNIC-(Fmoc) amino acids. Both procedures were compared and applied to the preparation of several HYNIC-oxytocin derivatives where ligand position and amino acid (lysine and phenylalanine) were varied. Additionally, an oxytocin derivative labeled with HYNIC in the alpha-amino group of the Cys1 residue was also prepared. 99mTc-ethylendiaminediacetic acid (EDDA) labeling efficiencies were examined for all the derivatives, resulting in two candidates which showed affinity for the oxytocin receptor. Further biochemical experiments demonstrated that 99mTc-EDDA/HYNIC-Cys1-OT-CONH2 could be used as a potential radiopharmaceutical for breast cancer diagnosis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

158186
Ethylenediamine-N,N′-diacetic acid, ≥98%
C6H12N2O4